General Information
Revision date
2023-03-13
Product name
Dantrolene sodium, ryanodine receptor antagonist
Substance name
Pure substance/mixture
CAS No.
14663-23-1
1.2.1 Relevant identified uses
For research use only. Not for use in diagnostic procedures
Icons in SDS
Company Information
company name
Abcam Australia Pty. Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
au.technical@abcam.com, sds@abcam.com
GHS Information
Signal word
WARNING
Hazard Codes
Hazard statements (CLP)
H341, H351, H361, H373
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
SECTION 2: Hazards identification
GHS Classification Germ cell mutagenicity Category 2 - (H341) Carcinogenicity Category 2 - (H351) Reproductive toxicity Category 2 - (H361) Specific target organ toxicity (repeated exposure) Category 2 - (H373) Label elements
Signal word
WARNING Hazard statements H341 - Suspected of causing genetic defects H351 - Suspected of causing cancer H361 - Suspected of damaging fertility or the unborn child H373 - May cause damage to organs through prolonged or repeated exposure Precautionary Statements - Prevention Obtain special instructions before use Do not handle until all safety precautions have been read and understood Wear protective gloves/clothing and eye/face protection Do not breathe dust/fume/gas/mist/vapours/spray Precautionary Statements - Response IF exposed or concerned: Get medical advice/attention Precautionary Statements - Storage Store locked up
Precautionary statements
Disposal Dispose of contents/container to an approved waste disposal plant
Other hazards which do not result in classification
Caution - substance not yet tested completely.
2.1 Classification of the substance or mixture
Category 2 - (H341) Carcinogenicity Category 2 - (H351) Reproductive toxicity Category 2 - (H361) Specific target organ toxicity (repeated exposure) Category 2 - (H373)
